ChromaDex (CDXC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CDXC ChromaDex

Watchlist

2.750
-0.130-4.51%

Close Aug 9 16:00 ET

2.740
-0.010-0.36%

Post 17:15 ET

208.82MMarket Cap-91666P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

HC Wainwright & Co. Reiterates Buy on ChromaDex, Maintains $6 Price Target
BenzingaAug 9 17:30 ET · Ratings
ChromaDex Analyst Ratings
BenzingaAug 9 17:29 ET · Ratings
Buy Rating Affirmed on Chromadex's Turnaround and Growth Prospects
TipRanksAug 9 08:11 ET · Ratings
Roth MKM Remains a Buy on Chromadex (CDXC)
TipRanksAug 8 09:43 ET · Ratings
Express News | ChromaDex Q2 Sales $22.739M Miss $23.437M Estimate
BenzingaAug 7 16:54 ET
ChromaDex GAAP EPS of $0.00 Beats by $0.01, Revenue of $22.7M Misses by $0.76M
Seeking AlphaAug 7 16:47 ET

Comments

Jaguar8

Jul 16 08:36

NEWS

$ChromaDex (CDXC.US)$
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
ChromaDex Corp. (NASDAQ:CDXC) announces the debut of pharmaceutical-grade Niagen® (nicotinamide riboside chloride) for intravenous and injectable use at leading wellness clinics in August. Wells Pharma of Houston, a U.S. FDA-registered 503B outsourcing facility, will compound and distribute Niagen+ to select IV clinics.
Niagen IV offers superior t...

Jaguar8

Apr 30 07:34

$ChromaDex (CDXC.US)$
NEWS
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement